Daniel Wolle

Stock Analyst at JP Morgan

(n/a)

# 4,476

Out of 4,789 analysts

3

Total ratings

n/a

Success rate

-39.16%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Daniel Wolle

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ITOS iTeos Therapeutics	Maintains: Overweight	$32 → $29	$5.63	+415.10%	2	Nov 13, 2023
	CARA Cara Therapeutics	Maintains: Overweight	$228 → $192	$4.94	+3,786.64%	1	Mar 7, 2023

iTeos Therapeutics

Nov 13, 2023

Maintains: Overweight

Price Target: $32 → $29

Current: $5.63

Upside: +415.10%

Cara Therapeutics

Mar 7, 2023

Maintains: Overweight

Price Target: $228 → $192

Current: $4.94

Upside: +3,786.64%